Suppr超能文献

以姜黄素为模型的混合聚合物-脂质纳米颗粒的设计:去甲氧基姜黄素和双去甲氧基姜黄素负载纳米颗粒的制备、表征及体外评价

Design of Hybrid Polymeric-Lipid Nanoparticles Using Curcumin as a Model: Preparation, Characterization, and In Vitro Evaluation of Demethoxycurcumin and Bisdemethoxycurcumin-Loaded Nanoparticles.

作者信息

Wilhelm Romero Krissia, Quirós María Isabel, Vargas Huertas Felipe, Vega-Baudrit José Roberto, Navarro-Hoyos Mirtha, Araya-Sibaja Andrea Mariela

机构信息

Laboratorio BIODESS, Escuela de Química, Universidad de Costa Rica, San Pedro de Montes de Oca, San José 2060, Costa Rica.

Laboratorio Nacional de Nanotecnología LANOTEC-CeNAT-CONARE, Pavas, San José 1174-1200, Costa Rica.

出版信息

Polymers (Basel). 2021 Nov 30;13(23):4207. doi: 10.3390/polym13234207.

Abstract

Polymeric lipid hybrid nanoparticles (PLHNs) are the new generation of drug delivery systems that has emerged as a combination of a polymeric core and lipid shell. We designed and optimized a simple method for the preparation of Pluronic F-127-based PLHNs able to load separately demethoxycurcumin (DMC) and bisdemethoycurcumin (BDM). CUR was used as a model compound due to its greater availability from turmeric and its structure similarity with DMC and BDM. The developed method produced DMC and BDM-loaded PLHNs with a size average of 75.55 ± 0.51 and 15.13 ± 0.014 nm for DMC and BDM, respectively. An FT-IR analysis confirmed the encapsulation and TEM images showed their spherical shape. Both formulations achieved an encapsulation efficiency ≥ 92% and an exhibited significantly increased release from the PLHN compared with free compounds in water. The antioxidant activity was enhanced as well, in agreement with the improvement in water dissolution; obtaining IC values of 12.74 ± 0.09 and 16.03 ± 0.55 for DMC and BDM-loaded PLHNs, respectively, while free curcuminoids exhibited considerably lower antioxidant values in an aqueous solution. Hence, the optimized PHLN synthesis method using CUR as a model and then successfully applied to obtain DMC and BDM-loaded PLHNs can be extended to curcuminoids and molecules with a similar backbone structure to improve their bioactivities.

摘要

聚合物脂质杂交纳米颗粒(PLHNs)是新一代药物递送系统,它是聚合物核与脂质壳的结合体。我们设计并优化了一种简单的方法来制备基于普朗尼克F - 127的PLHNs,该纳米颗粒能够分别负载去甲氧基姜黄素(DMC)和双去甲氧基姜黄素(BDM)。由于姜黄素(CUR)在姜黄中更容易获得且其结构与DMC和BDM相似,因此被用作模型化合物。所开发的方法制备出的负载DMC和BDM的PLHNs,其平均粒径对于DMC和BDM分别为75.55±0.51纳米和15.13±0.014纳米。傅里叶变换红外光谱(FT - IR)分析证实了包封情况,透射电子显微镜(TEM)图像显示了它们的球形形状。两种制剂的包封效率均≥92%,并且与水中的游离化合物相比,从PLHN中的释放显著增加。抗氧化活性也得到了增强,这与在水中溶解度的提高一致;负载DMC和BDM的PLHNs的半数抑制浓度(IC)值分别为12.74±0.09和16.03±0.55,而游离姜黄素类化合物在水溶液中的抗氧化值则低得多。因此,以CUR为模型优化的PHLN合成方法,随后成功应用于获得负载DMC和BDM的PLHNs,可扩展到姜黄素类化合物以及具有类似主链结构的分子,以提高它们的生物活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b78/8659538/3b4a152a12fd/polymers-13-04207-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验